glp-1-directed nmda receptor antagonism for obesity treatment Transforming obesity: The advancement of multi-receptor drugs: Cell Targeting Obesity: GLP-1R, GIPR, GDF8
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
























